General information and education, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Always consult a SEBI-registered adviser.
1. At a Glance
A dental materials maker in Bari Brahmana, Jammu, reported sales of ₹19.44 crore for the three months to June 2026. That is 23.7% above the same quarter a year earlier. It is the highest quarterly sales figure across the ten quarters the company has reported. Operating profit was ₹6.89 crore and net profit ₹5.78 crore. Earnings per share, which is profit divided by the number of shares, came to ₹4.82.
The borrowings line on this balance sheet has been blank since March 2023. ‘Almost debt free’ gets treated as a personality trait in this market, and here the line is simply empty. Interest cost in the quarterly statement is a row that exists out of formatting courtesy.
Inventory days measure how long stock sits in the building before it is sold. The figure reached 235 in the year to March 2026, up from 208. Somewhere in a 60,000 sq ft facility, root canal sealant is ageing like it has ambitions in the wine trade.
Management disclosed that the new Labour Codes, in force from 1 April 2026, raised employee benefit expense for the quarter by ₹27.80 lakh. Employee cost for the quarter was ₹338.23 lakh on a standalone basis.
Other income for the quarter was ₹1.33 crore, against operating profit of ₹6.89 crore. Cash and bank balances stood at ₹72.65 crore as at March 2026.
Promoter holding has been 73.60% for twelve straight quarters, to the second decimal place.
2. Introduction
The company was incorporated in 1999, according to its own investor presentation. Screener’s About section dates it to 2000 instead. By the company’s account it began in a 200 square foot manufacturing unit, roughly the footprint of a generous studio flat. It now works out of a 60,000 sq ft plant in the Export Promotion Industrial Park at Bari Brahmana, Jammu. An in-house research and development lab is attached to it. The shares were listed on the BSE SME platform in 2021.
The strategic timeline in the presentation for the year to March 2026 reads like a company that discovered geography. Axiodent Inc. was established in the United States in 2024. In 2025 the company signed memorandums of understanding with the Indian Dental Association for clinical education and with IIT Kanpur for biomaterials and biomedical devices. Prevest Gulf LLC was established in the UAE, and capital went into that Gulf subsidiary during the year. In February 2025 the company disclosed an investment of USD 50,000 into Axiodent Inc.
Four entities now consolidate into the group: the holding company, Denvisio Biomed Limited, Axiodent Inc. and Prevest Denpro Gulf General Trading LLC. Denvisio Biomed was incorporated in May 2023. The auditors noted that the two foreign subsidiaries together contributed revenue of ₹5.71 lakh in the June 2026 quarter. The auditors also recorded a net loss after tax of ₹16.81 lakh before consolidation adjustments. Management represented both figures as not material to the group.
On certifications, the company lists ISO 13485-2016, ISO 22716 and an EC certificate. It also lists USFDA, Saudi FDA and MDSAP approvals. A dental materials maker collects regulatory approvals the way other companies collect subsidiaries, and this one does both.
For the year to March 2026 the company declared a final dividend of ₹1.00 per share on a face value of ₹10. That is a 10% dividend, the same rate as the maiden dividend announced in 2023. The dividend amount has been ₹1.2 crore in each of the last four financial years.
US
Now live
US Stocks terminal is live
13,000+ US tickers · EDGAR fundamentals · screener and filings feed — the same terminal, for American markets.
Explore →
3. Business Model: WTF Do They Even Do?
The company makes the materials a dentist puts into a patient’s mouth after removing the bits that offended them.
The portfolio runs past 100 products. Restorative materials for filling cavities are sold as Crysta Restorative and Fusion Restorative Kits. Endodontic solutions, meaning root canal work, are sold as Endoseal. Preventive care after extractions and against decay covers Alvocure and the Fusion Flo Combo Kit. There are orthodontic adhesives for braces and aligners, plus impression materials and cements such as Crysta Luting and Fusion I-Seal. Brands include Micron, Actino, Fusion Flo and Activa, with Enamel Pro alongside them. One product is called Endoseal MICRON SUPERIOR, which is what happens when marketing and R&D are on speaking terms.
Two categories opened in the year to March 2026. Digital dentistry is sold under the Omni brand, covering 3D printing resins and, from November, the printers themselves. The other is disinfectants, which management describes as having begun commercial scale-up during the year.
The distribution machinery looks large beside revenue of ₹71.66 crore for that year. Exports go to more than 90 countries, supported by 145 dealers in India and 120 overseas business partners. Screener’s extracted operating data shows dealers in India rising from 60 to 145 in the latest year. The same data shows overseas agents going from 90 to 120. Somebody has been very busy signing people up.
Capacity utilisation on the core traditional lines runs at roughly 67 to 68%. Management stated that at full utilisation turnover would be around ₹125 crore. The newer lines run at approximately 18 to 20% utilisation: digital dentistry, resins, disinfectants and oral
